These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20848663)

  • 41. [Advancement of studies on ALDH1 as a universal marker of stem cells].
    Han M; Wu C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Oct; 27(5):1183-6. PubMed ID: 21089696
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ALDH as a marker for enriching tumorigenic human colonic stem cells.
    Shenoy A; Butterworth E; Huang EH
    Methods Mol Biol; 2012; 916():373-85. PubMed ID: 22914954
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sca-1+ cells from fetal heart with high aldehyde dehydrogenase activity exhibit enhanced gene expression for self-renewal, proliferation, and survival.
    Dey D; Pan G; Varma NR; Palaniyandi SS
    Oxid Med Cell Longev; 2015; 2015():730683. PubMed ID: 25861413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aldehyde dehydrogenase activity is a cancer stem cell marker of tongue squamous cell carcinoma.
    Zou B; Sun S; Qi X; Ji P
    Mol Med Rep; 2012 Apr; 5(4):1116-20. PubMed ID: 22307065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform.
    Marcato P; Dean CA; Giacomantonio CA; Lee PW
    Cell Cycle; 2011 May; 10(9):1378-84. PubMed ID: 21552008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation and Isolation of Cancer Stem Cells Using ALDH Activity Assay.
    Mele L; Liccardo D; Tirino V
    Methods Mol Biol; 2018; 1692():43-48. PubMed ID: 28986885
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ALDH as a Stem Cell Marker in Solid Tumors.
    Toledo-Guzmán ME; Hernández MI; Gómez-Gallegos ÁA; Ortiz-Sánchez E
    Curr Stem Cell Res Ther; 2019; 14(5):375-388. PubMed ID: 30095061
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells.
    Vasiliou V; Thompson DC; Smith C; Fujita M; Chen Y
    Chem Biol Interact; 2013 Feb; 202(1-3):2-10. PubMed ID: 23159885
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mesenchymal Stem/Stromal Cells Derived From a Reproductive Tissue Niche Under Oxidative Stress Have High Aldehyde Dehydrogenase Activity.
    Kusuma GD; Abumaree MH; Pertile MD; Perkins AV; Brennecke SP; Kalionis B
    Stem Cell Rev Rep; 2016 Jun; 12(3):285-97. PubMed ID: 26880140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of a novel marker of brain tumor stem cells.
    Engh JA
    Neurosurgery; 2010 Oct; 67(4):N16. PubMed ID: 20881541
    [No Abstract]   [Full Text] [Related]  

  • 51. ALDEFLUOR activity, ALDH isoforms, and their clinical significance in cancers.
    Duan JJ; Cai J; Gao L; Yu SC
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2166035. PubMed ID: 36651035
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Next generation of ALDH substrates and their potential to study maturational lineage biology in stem and progenitor cells.
    Dollé L; Boulter L; Leclercq IA; van Grunsven LA
    Am J Physiol Gastrointest Liver Physiol; 2015 Apr; 308(7):G573-8. PubMed ID: 25656041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Role of ALDH in the Metastatic Potential of Osteosarcoma Cells and Potential ALDH Targets.
    Belayneh R; Weiss K
    Adv Exp Med Biol; 2020; 1258():157-166. PubMed ID: 32767240
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress.
    Singh S; Brocker C; Koppaka V; Chen Y; Jackson BC; Matsumoto A; Thompson DC; Vasiliou V
    Free Radic Biol Med; 2013 Mar; 56():89-101. PubMed ID: 23195683
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aldehyde Dehydrogenase Inhibitors for Cancer Therapeutics.
    Dinavahi SS; Bazewicz CG; Gowda R; Robertson GP
    Trends Pharmacol Sci; 2019 Oct; 40(10):774-789. PubMed ID: 31515079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells.
    Vassalli G
    Stem Cells Int; 2019; 2019():3904645. PubMed ID: 30733805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Proportion of ALDEFLUOR-Positive Cancer Stem Cells Changes with Cell Culture Density Due to the Expression of Different ALDH Isoforms.
    Opdenaker LM; Modarai SR; Boman BM
    Cancer Stud Mol Med; 2015; 2(2):87-95. PubMed ID: 28280782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The expression of aldehyde dehydrogenase family in breast cancer.
    Qiu Y; Pu T; Li L; Cheng F; Lu C; Sun L; Teng X; Ye F; Bu H
    J Breast Cancer; 2014 Mar; 17(1):54-60. PubMed ID: 24744798
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a Retinal-Based Probe for the Profiling of Retinaldehyde Dehydrogenases in Cancer Cells.
    Koenders STA; Wijaya LS; Erkelens MN; Bakker AT; van der Noord VE; van Rooden EJ; Burggraaff L; Putter PC; Botter E; Wals K; van den Elst H; den Dulk H; Florea BI; van de Water B; van Westen GJP; Mebius RE; Overkleeft HS; Le Dévédec SE; van der Stelt M
    ACS Cent Sci; 2019 Dec; 5(12):1965-1974. PubMed ID: 31893226
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 5-Nitrofurans and Cancer: Teaching an Old Drug New Tricks.
    Peterson RT
    Cell Chem Biol; 2018 Dec; 25(12):1439-1440. PubMed ID: 30576659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.